A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

NCT06782373 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

VEXAS
VEXAS Syndrome

Interventions

DRUG: Pacritinib
DRUG: Placebo

Sponsor

Swedish Orphan Biovitrum

Collaborators

[object Object]